Putting gold nanocages to work for optical imaging, controlled release and cancer theranostics
Abstract
Gold nanocages are hollow nanostructures with ultrathin, porous walls. They are bio-inert and their surface can be readily modified with functional groups to specifically interact with the biological system of interest. They have remarkable optical properties, including localized surface plasmon resonance peaks tunable to the near-infrared region, strong absorption and scattering, as well as two- and three-photon luminescence. With the establishment of robust protocols for both synthesis and surface functionalization, Au nanocages have been extensively explored for various biomedical applications. In this review, we begin with a brief account of the synthesis and properties of Au nanocages, and then highlight some of the recent developments in applying them to an array of biomedical applications related to optical imaging, controlled release and cancer theranostics.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1 . The golden age: gold nanoparticle for biomedicine. Chem. Soc. Rev. 41(7), 2740–2779 (2012).
- 2 . Nanoparticle probes for the detection of cancer biomarkers, cells, and tissues by fluorescence. Chem. Rev. 115(19), 10530–10574 (2015).
- 3 . Nanomedicine applications of hybrid nanomaterials built from metal-ligand coordination bonds: nanoscale metal-organic frameworks and nanoscale coordination polymers. Chem. Rev. 115(19), 11079–11108 (2015).
- 4 . Impact of nanotechnology on drug delivery. ACS Nano 3(1), 16–20 (2009).
- 5 . Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv. Drug Deliv. Rev. 66, 2–25 (2014).
- 6 . The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv. Drug Deliv. Rev. 65(1), 71–79 (2013).
- 7 . Nanoparticles in drug delivery: past, present and future. Adv. Drug Deliv. Rev. 65(1), 21–23 (2013).
- 8 . Multifunctional nanoparticles for drug delivery and molecular imaging. Annu. Rev. Biomed. Eng. 15(1), 253–282 (2013).
- 9 . Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2(12), 751–760 (2007).
- 10 . Engineered nanoparticles for drug delivery in cancer therapy. Angew. Chem. Int. Ed. Engl. 53(46), 12320–12364 (2014).
- 11 . Gold nanocages as multifunctional materials for nanomedicine. Front. Phys. 9(3), 378–384 (2014).
- 12 Gold nanocages: from synthesis to theranostic applications. Acc. Chem. Res. 44(10), 914–924 (2011).
- 13 . Gold nanostructures: a class of multifunctional materials for biomedical applications. Chem. Soc. Rev. 40(1), 44–56 (2011).
- 14 . A clearer vision for in vivo imaging. Nat. Biotechnol. 19(4), 316–317 (2001).
- 15 . Seeded growth of submicron Au colloids with quadrupole plasmon resonance modes. Langmuir 22(16), 7007–7010 (2006).
- 16 . Gold nanocages for cancer detection and treatment. Nanomedicine 2(5), 657–668 (2007).
- 17 . Template-engaged replacement reaction: a one-step approach to the large-scale synthesis of metal nanostructures with hollow interiors. Nano Lett. 2(5), 481–485 (2002). • The first report on the use of galvanic replacement reaction at the nanometer scale with multiple-twined Ag nanoparticles serving as the sacrificial templates.
- 18 . Shape-controlled synthesis of gold and silver nanoparticles. Science 298(5601), 2176–2179 (2002). •• The first report on the synthesis of well-defined and controllable Au nanocages via the galvanic replacement reaction with single-crystal Ag nanocubes.
- 19 Gold nanocages: synthesis, properties, and applications. Acc. Chem. Res. 41(12), 1587–1595 (2008).
- 20 . Facile synthesis of Ag nanocubes and Au nanocages. Nat. Protocols 2(9), 2182–2190 (2007).
- 21 . Fabrication of cubic nanocages and nanoframes by dealloying Au/Ag alloy nanoboxes with an aqueous etchant based on Fe(NO3)3 or NH4OH. Nano Lett. 7(6), 1764–1769 (2007).
- 22 . Dissolving Ag from Au-Ag alloy nanoboxes with H2O2: a method for both tailoring the optical properties and measuring the H2O2 concentration. J. Phys. Chem. C 114(14), 6396–6400 (2010).
- 23 . Gold nanomaterials at work in biomedicine. Chem. Rev. 115(19), 10410–10488 (2015). • A comprehensive review of the application of Au nanomaterials in biomedical research.
- 24 . A plasmon-assisted optofluidic (PAOF) system for measuring the photothermal conversion efficiencies of gold nanostructures and controlling an electrical switch. Angew. Chem. Int. Ed. Engl. 52(15), 4169–4173 (2013).
- 25 Measuring the optical absorption cross sections of Au-Ag nanocages and Au nanorods by photoacoustic imaging. J. Phys. Chem. C 113(21), 9023–9028 (2009).
- 26 Gold nanostructures: engineering their plasmonic properties for biomedical applications. Chem. Soc. Rev. 35(11), 1084–1094 (2006).
- 27 . On the polyol synthesis of silver nanostructures: glycolaldehyde as a reducing agent. Nano Lett. 8(7), 2077–2081 (2008).
- 28 . Polyol synthesis of silver nanoparticles: use of chloride and oxygen to promote the formation of single-crystal, truncated cubes and tetrahedrons. Nano Lett. 4(9), 1733–1739 (2004).
- 29 . Quantitative analysis of the role played by poly(vinylpyrrolidone) in seed-mediated growth of Ag nanocrystals. J. Am. Chem. Soc. 134(3), 1793–1801 (2011).
- 30 . Rapid synthesis of small silver nanocubes by mediating polyol reduction with a trace amount of sodium sulfide or sodium hydrosulfide. Chem. Phys. Lett. 432(4–6), 491–496 (2006).
- 31 Production of Ag nanocubes on a scale of 0.1 g per batch by protecting the NaHS-mediated polyol synthesis with argon. ACS Appl. Mater. Interfaces 1(9), 2044–2048 (2009).
- 32 . Facile synthesis of Ag nanocubes of 30 to 70 nm in edge length with CF3COOAg as a precursor. Chem. Eur. J. 16(33), 10234–10239 (2010). • The most robust method for the synthesis of Ag nanocube.
- 33 Gold nanocages: a novel class of multifunctional nanomaterials for theranostic applications. Adv. Funct. Mater. 20(21), 3684–3694 (2010).
- 34 . Synthesis of Ag nanocubes 18–32 nm in edge length: the effects of polyol on reduction kinetics, size control, and reproducibility. J. Am. Chem. Soc. 135(5), 1941–1951 (2013). • A recent report on the synthesis of Ag nanocubes as small as 18 nm in edge length and Au nanocages as small as 20 nm in edge length.
- 35 . Toward the synthesis of sub-15 nm Ag nanocubes with sharp corners and edges: the roles of heterogeneous nucleation and surface capping. J. Am. Chem. Soc. 138(9), 3161–3167 (2016).
- 36 Quantifying the cellular uptake of antibody-conjugated Au nanocages by two-photon microscopy and inductively coupled plasma mass spectrometry. ACS Nano 4(1), 35–42 (2009).
- 37 . Bright three-photon luminescence from gold/silver alloyed nanostructures for bioimaging with negligible photothermal toxicity. Angew. Chem. Int. Ed. Engl. 49(20), 3485–3488 (2010).
- 38 . Quantitative analysis of the fate of gold nanocages in vitro and in vivo after uptake by U87-MG tumor cells. Angew. Chem. Int. Ed. Engl. 52(4), 1152–1155 (2013).
- 39 Labeling human mesenchymal stem cells with gold nanocages for in vitro and in vivo tracking by two-photon microscopy and photoacoustic microscopy. Theranostics 3(8), 532–543 (2013).
- 40 . Photoacoustic tomography of a rat cerebral cortex in vivo with Au nanocages as an optical contrast agent. Nano Lett. 7(12), 3798–3802 (2007).
- 41 . Near-infrared gold nanocages as a new class of tracers for photoacoustic sentinel lymph node mapping on a rat model. Nano Lett. 9(1), 183–188 (2009).
- 42 In vivo molecular photoacoustic tomography of melanomas targeted by boconjugated gold nanocages. ACS Nano 4(8), 4559–4564 (2010).
- 43 Radioluminescent gold nanocages with controlled radioactivity for real-time in vivo imaging. Nano Lett. 13(2), 581–585 (2013). •• A report on the incorporation of 198Au into the crystal lattice of Au nanocages. Most recently, the same approach has been employed by many groups for the labeling of nanostructures with radioactive isotopes for nuclear imaging.
- 44 In vitro and in vivo two-photon luminescence imaging of single gold nanorods. Proc. Natl Acad. Sci. USA 102(44), 15752–15756 (2005).
- 45 . Two-photon luminescence properties of gold nanorods. Biomed. Opt. Express 4(4), 584–595 (2013).
- 46 . The ‘lightning’ gold nanorods: fluorescence enhancement of over a million compared with the gold metal. Chem. Phys. Lett. 317(6), 517–523 (2000).
- 47 . Photoluminescence of metals. Phys. Rev. Lett. 22(5), 185–187 (1969).
- 48 . Nanoparticles for photoacoustic imaging. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1(4), 360–368 (2009).
- 49 . In vivo photoacoustic tomography of chemicals: high-resolution functional and molecular optical imaging at new depths. Chem. Rev. 110(5), 2756–2782 (2010).
- 50 . Optical-resolution photoacoustic microscopy for in vivo imaging of single capillaries. Opt. Lett. 33(9), 929–931 (2008).
- 51 . Molecular imaging of cancer with positron emission tomography. Nat. Rev. Cancer 2(9), 683–693 (2002).
- 52 . PET and SPECT in cardiovascular molecular imaging. Nat. Rev. Cardiol. 7(1), 38–47 (2010).
- 53 Evaluating the pharmacokinetics and in vivo cancer targeting capability of Au nanocages by positron emission tomography imaging. ACS Nano 6(7), 5880–5888 (2012).
- 54 Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl Acad. Sci. USA 100(23), 13549–13554 (2003).
- 55 . Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Laser Med. Sci. 23(3), 217–228 (2008).
- 56 . Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc. 128(6), 2115–2120 (2006).
- 57 . Tailoring the structure of nanopyramids for optimal heat generation. Nano Lett. 9(4), 1555–1558 (2009).
- 58 Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. Nano Lett. 7(5), 1318–1322 (2007).
- 59 Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment. ACS Nano 7(3), 2068–2077 (2013).
- 60 Gold nanocages: Bioconjugation and their potential use as optical imaging contrast agents. Nano Lett. 5(3), 473–477 (2005).
- 61 Gold nanocages as photothermal transducers for cancer treatment. Small 6(7), 811–817 (2010).
- 62 . Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Phil. Trans. R. Soc. A 368(1915), 1333–1383 (2010).
- 63 ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG), influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf. B Biointerfaces 18(3–4), 301–313 (2000).
- 64 Quantifying the coverage density of poly(ethylene glycol) chains on the surface of gold nanostructures. ACS Nano 6(1), 512–522 (2011).
- 65 An enzyme-sensitive probe for photoacoustic imaging and fluorescence detection of protease activity. Nanoscale 3(3), 950–953 (2011).
- 66 . Gold nanoparticles for molecular diagnostics. Expert Rev. Mol. Diagn. 9(5), 511–524 (2009).
- 67 Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat. Mater. 8(12), 935–939 (2009). • An early report on the controlled release of drugs from the interiors of Au nanocages through the use of smart polymer brushes as the ‘gate keeper’.
- 68 A new theranostic system based on gold nanocages and phase-change materials with unique features for photoacoustic imaging and controlled release. J. Am. Chem. Soc. 133(13), 4762–4765 (2011).
- 69 . Hydrogels for biomedical applications. Adv. Drug Delivery Rev. 54(1), 3–12 (2002).
- 70 Gold nanocages covered with thermally-responsive polymers for controlled release by high-intensity focused ultrasound. Nanoscale 3(4), 1724–1730 (2011).
- 71 . A temperature-sensitive drug release system based on phase-change materials. Angew. Chem. Int. Ed. Engl. 49(43), 7904–7908 (2010).